{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:54:57Z","timestamp":1778151297872,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.cancergencyto.2005.01.018","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:35:40Z","timestamp":1124019340000},"page":"181-186","source":"Crossref","is-referenced-by-count":5,"title":["Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines"],"prefix":"10.1016","volume":"161","author":[{"given":"Zaira M.","family":"Limongi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.01.018_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0168-9525(98)01628-X","article-title":"Fragile sites still breaking","volume":"14","author":"Sutherland","year":"1998","journal-title":"Trends Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-9525(01)02303-4","article-title":"Fragile and unstable chromosomes in cancer: causes and consequences","volume":"17","author":"Richards","year":"2001","journal-title":"Trends Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/hmg\/5.2.187","article-title":"FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites","volume":"5","author":"Wilke","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)80201-9","article-title":"Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons","volume":"89","author":"Coquelle","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib5","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/hmg\/11.23.2887","article-title":"Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I","volume":"11","author":"Ciullo","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1535-6108(02)00017-X","article-title":"A role for common fragile site induction in amplification of human oncogenes","volume":"1","author":"Hellman","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib7","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0888-7543(03)00007-7","article-title":"Characterization of the human common fragile site FRA2G","volume":"81","author":"Limongi","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib9","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1038\/sj.onc.1207072","article-title":"Alterations in the common fragile site gene Parkin in ovarian and other cancers","volume":"22","author":"Denison","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib10","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1038\/sj.onc.1205573","article-title":"Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors","volume":"21","author":"Morelli","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib11","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/sj.onc.1200202","article-title":"FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites","volume":"16","author":"Huang","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib12","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1073\/pnas.95.14.8141","article-title":"Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site","volume":"95","author":"Mishmar","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.onc.1206171","article-title":"Characterization of the common fragile site FRA9E and its potential role in ovarian cancer","volume":"22","author":"Callahan","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib14","first-page":"1683","article-title":"Chromosomal fragile site FRA16D and DNA instability in cancer","volume":"60","author":"Mangelsdorf","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib15","first-page":"1690","article-title":"A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D","volume":"60","author":"Paige","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/hmg\/9.11.1651","article-title":"Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells","volume":"9","author":"Ried","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.10000","article-title":"Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells","volume":"33","author":"Arlt","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib18","unstructured":"Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated May 2004. Available from http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib19","doi-asserted-by":"crossref","first-page":"22278","DOI":"10.1074\/jbc.M102076200","article-title":"Characterization of a novel type of human microsomal 3\u03b1-hydroxysteroid dehydrogenase: unique tissue distribution and catalytic properties","volume":"276","author":"Chetyrkin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib20","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M100332200","article-title":"Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase\/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol","volume":"276","author":"Soref","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib21","doi-asserted-by":"crossref","first-page":"34397","DOI":"10.1074\/jbc.M314021200","article-title":"The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L","volume":"279","author":"Jette","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7788","article-title":"Embryonic retinoic acid synthesis is essential for early mouse post-implantation development","volume":"4","author":"Niederreither","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#","article-title":"Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells","volume":"185","author":"Mira-y-Lopez","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib24","first-page":"1196","article-title":"retSDR1, a short-chain retinol dehydrogenase\/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines","volume":"62","author":"Cerignoli","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.018_bib25","first-page":"1654","article-title":"Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens","volume":"62","author":"Guo","year":"2002","journal-title":"Cancer Res"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T18:55:04Z","timestamp":1548269704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0165460805001123"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.01.018","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}